Based on previous research strategies and a large T2DM clinical trial cohort, we conducted an association study between common genetic variations of RASGRP1 and vascular complications under hypoglycemic or hypertensive therapy, aiming to understand the genetic effects of T2DM on drug therapy from a more comprehensive perspective. The gene discussed is RASGRP1; the disease is type 2 diabetes mellitus.